hit counter
Axsome Therapeutics, Inc. (AXSM) Stock News Sentiment & Price - Sentifly
AXSM - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Axsome Therapeutics, Inc. (AXSM)

USA
Biotechnology
NASDAQ
AXSM Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AXSM Latest news
Zacks Investment Research
Positive
How Much Upside is Left in Axsome (AXSM)? Wall Street Analysts Think 144%
2021-11-10 11:28

The average of price targets set by Wall Street analysts indicates a potential upside of 143.7% in Axsome (AXSM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research
Positive
Axsome (AXSM) Q3 Earnings Top, Pre-Launch Activities Continue
2021-11-09 11:28

Axsome Therapeutics (AXSM) reports a narrower-than-expected Q3 loss. The company is actively preparing to support the commercial launch of its two under-review candidates, AXS-05 and AXS-07.

Seeking Alpha
Neutral
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q3 2021 Results - Earnings Call Transcript
2021-11-08 13:34

Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q3 2021 Results - Earnings Call Transcript

The Motley Fool
Positive
Why Axsome Therapeutics Stock Is Rising Today
2021-11-08 12:37

The company provided its third-quarter update.

GlobeNewsWire
Neutral
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
2021-11-08 07:00

Company to host conference call today at 8:00 AM Eastern

Zacks Investment Research
Positive
Biotech Stocks' Q3 Earnings on Nov 8: VTRS, EDIT & More
2021-11-05 11:28

Let us look at four drug/biotech companies, VTRS, RDUS, AXSM and EDIT, which are gearing up for their earnings release.

GlobeNewsWire
Neutral
Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021
2021-10-20 07:00

Axsome to host conference call and webcast on Monday, November 8, 2021 at 8:00 AM Eastern Time

Forbes
Positive
What's Happening With Axsome Therapeutics Stock?
2021-10-18 11:00

Last month we discussed that Axsome Therapeutics stock is likely to continue to see higher levels after it rose 6% in a week following the U.S. FDA's acceptance of a new drug application for the company's migraine drug - AXS-07. AXSM stock has since then rallied 27% to levels of nearly $38 now.

GlobeNewsWire
Neutral
Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million
2021-10-18 07:00

$100 million now available upon the potential FDA approval of AXS-05

The Motley Fool
Positive
Why Axsome Therapeutics Stock Rocketed Higher This Week
2021-10-15 10:00

Optimism among investors is growing for the possible approval of the biotech's MDD drug.

Loading more news...